Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia

Ravi Kant; Shashi Kala Kumari; Nibha; Jayendra Kumar

doi:10.5455/IJMRCR.172-1669482402

2023, Vol: 7, Issue: 6

7 / 6Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Copyright Transfer Form

« Previous Article

Original Research

Online Publishing Date:
18 / 12 / 2022

Int J Med Rev Case Rep. 2022; 6(21): 31-35

doi: 10.5455/IJMRCR.172-1669482402

Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia

Ravi Kant, Shashi Kala Kumari, Nibha, Jayendra Kumar.

Abstract
Background: Patients with dementia have higher levels of peripheral inflammatory markers. We investigated whether midlife levels of interleukin-6 (IL-6) and C-reactive protein (CRP) predicted concurrently evaluated intelligence and eventual cognitive impairment in order to determine their causal function.
Method: In the cohort study, the mean values of IL-6 and CRP were measured in 100 individuals taking irregular supplements of vitamins (27.8% of whom were women) between Oct 2019 and May 2020 and June 2020 and Oct 2020. These values were then divided into tertiles to examine a 1-year decline in the mean (mean = 1, SD = 2) standardised scores of verbal fluency, memory, and reasoning. Logistic regression was used to model declines greater than 2 points. For the baseline age, sex, and education, as well as for subsequent analyses, adjustments were made to the analyses.
Result: In cross-sectional research, participants with high IL-6 levels had poorer reasoning scores (0.08 SD; 95% [CI] 20.13, 20.02). In a retrospective study, participants with high IL-6 had a 1-year reduction in reasoning that was larger (p-value = 0.02) than that of those with low IL-6 (20.28; 90% CI 20.30, 20.26) (20.34; 90% CI 20.36, 20.32). In none of the tests, CRP was connected to deterioration.
Conclusion: The overall cross-sectional and long term impacts across the 1-year observation time approximated to an age effect of 2.5 months; elevated IL-6 but not CRP in midlife indicates cognitive deterioration.

Key words: Interleukin-6, C-reactive protein, Dementia, cognitive impairment

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Ravi Kant Articles by Shashi Kala Kumari Articles by Nibha Articles by Jayendra Kumar
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Kant R, Kumari SK, Nibha , Kumar J. Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia. Int J Med Rev Case Rep. 2022; 6(21): 31-35. doi:10.5455/IJMRCR.172-1669482402

Web Style

Kant R, Kumari SK, Nibha , Kumar J. Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia. https://www.mdpub.net/?mno=132906 [Access: April 05, 2024]. doi:10.5455/IJMRCR.172-1669482402

AMA (American Medical Association) Style

Kant R, Kumari SK, Nibha , Kumar J. Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia. Int J Med Rev Case Rep. 2022; 6(21): 31-35. doi:10.5455/IJMRCR.172-1669482402

Vancouver/ICMJE Style

Kant R, Kumari SK, Nibha , Kumar J. Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia. Int J Med Rev Case Rep. (2022), [cited April 05, 2024]; 6(21): 31-35. doi:10.5455/IJMRCR.172-1669482402

Harvard Style

Kant, R., Kumari, . S. K., Nibha, . & Kumar, . J. (2022) Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia. Int J Med Rev Case Rep, 6 (21), 31-35. doi:10.5455/IJMRCR.172-1669482402

Turabian Style

Kant, Ravi, Shashi Kala Kumari, Nibha, and Jayendra Kumar. 2022. Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia. International Journal of Medical Reviews and Case Reports, 6 (21), 31-35. doi:10.5455/IJMRCR.172-1669482402

Chicago Style

Kant, Ravi, Shashi Kala Kumari, Nibha, and Jayendra Kumar. "Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia." International Journal of Medical Reviews and Case Reports 6 (2022), 31-35. doi:10.5455/IJMRCR.172-1669482402

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Kant, R., Kumari, . S. K., Nibha, . & Kumar, . J. (2022) Interleukin-6 and C-reactive protein as indicators of late-life cognitive decline in dementia. International Journal of Medical Reviews and Case Reports, 6 (21), 31-35. doi:10.5455/IJMRCR.172-1669482402

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.

For best results, please use Internet Explorer or Google Chrome.

Contact Information

Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31, Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press.

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500

About International Journal of Medical Reviews and Case Reports

Contact Information

How to cite this article